世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

乳がんリキッドバイオプシー検査装置の世界市場 2022-2026


Global Breast Cancer Liquid Biopsy Testing Devices Market 2022-2026

乳がんリキッドバイオプシー検査装置の世界市場2022-2026年 Technavioは乳癌リキッドバイオプシー検査装置市場を監視しており、2022-2026年の間に730.4百万ドルの成長が見込まれ、予測期間中にCAGR23.58%で加速... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年6月7日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

乳がんリキッドバイオプシー検査装置の世界市場2022-2026年
Technavioは乳癌リキッドバイオプシー検査装置市場を監視しており、2022-2026年の間に730.4百万ドルの成長が見込まれ、予測期間中にCAGR23.58%で加速しています。当レポートでは、乳がんリキッドバイオプシー検査装置市場の全体分析、市場規模・予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、乳がんの有病率の増加、非侵襲的な処置への嗜好の高まり、新製品の上市やFDA承認の増加によって牽引されています。
乳がんリキッドバイオプシー検査装置市場の分析には、タイプ別セグメントと地域別の展望が含まれます。
Technavioの乳がんリキッドバイオプシー検査装置市場は、以下のようにセグメント化されています。
タイプ別
- CTCおよび循環核酸
- 細胞外ベシクル
地理的状況別
- 北米
- 欧州
- アジア
- その他の地域(ROW)
本調査では、今後数年間における乳がんリキッドバイオプシー検査装置市場の成長を促進する主要な理由の一つとして、技術的進歩を挙げています。また、乳がん診断の重視の高まりと顧客直販の増加も、市場の大きな需要につながるだろう。
Technavioは、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。乳がんのリキッドバイオプシー検査装置市場に関する当レポートは、以下の分野を対象としています。
- 乳がんリキッドバイオプシー検査装置市場のサイジング
- 乳がんリキッドバイオプシー検査装置市場予測
- 乳がん液体生検検査装置市場の産業分析
Technavioの堅牢なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、A.Menarini Industrie Farmaceutiche Riunite Srl、Agena Bioscience Inc、Bio Rad Laboratories Inc、Exact Sciences Corp、F. Hoffmann La Roche Ltd.、Fluxion Biosciences Inc、Guardant Health Inc、Illumina Inc.、Isogen Life Science BV、Illumina Inc,Isogen Life Science BV、Myriad Genetics Inc、Natera Inc、NeoGenomics Laboratories Inc、Novogene Corp、OncoDNA SA、Pfizer Inc、QIAGEN NV、SAGA Diagnostics AB、Sysmex Corp、および Thermo Fisher Scientific Inc.は、乳がんリキッドバイオプシーを開発するために必要な情報を提供します。また、乳がんリキッドバイオプシー検査装置市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/global-breast-cancer-liquid-biopsy-testing-devices-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 CTCs and circulating nucleic acids - Market size and forecast 2021-2026
o Exhibit 28: Chart on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
o 5.4 Extracellular vesicles - Market size and forecast 2021-2026
o Exhibit 32: Chart on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 Canada - Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 A. Menarini Industrie Farmaceutiche Riunite Srl
o Exhibit 89: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
o Exhibit 90: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
o Exhibit 91: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
o 10.4 Exact Sciences Corp.
o Exhibit 92: Exact Sciences Corp. - Overview
o Exhibit 93: Exact Sciences Corp. - Product / Service
o Exhibit 94: Exact Sciences Corp. - Key offerings
o 10.5 F. Hoffmann La Roche Ltd.
o Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
o 10.6 Illumina Inc.
o Exhibit 100: Illumina Inc. - Overview
o Exhibit 101: Illumina Inc. - Business segments
o Exhibit 102: Illumina Inc. - Key news
o Exhibit 103: Illumina Inc. - Key offerings
o Exhibit 104: Illumina Inc. - Segment focus
o 10.7 Isogen Life Science BV
o Exhibit 105: Isogen Life Science BV - Overview
o Exhibit 106: Isogen Life Science BV - Product / Service
o Exhibit 107: Isogen Life Science BV - Key offerings
o 10.8 Myriad Genetics Inc.
o Exhibit 108: Myriad Genetics Inc. - Overview
o Exhibit 109: Myriad Genetics Inc. - Product / Service
o Exhibit 110: Myriad Genetics Inc. - Key offerings
o 10.9 Natera Inc.
o Exhibit 111: Natera Inc. - Overview
o Exhibit 112: Natera Inc. - Product / Service
o Exhibit 113: Natera Inc. - Key offerings
o 10.10 Novogene Corp.
o Exhibit 114: Novogene Corp. - Overview
o Exhibit 115: Novogene Corp. - Product / Service
o Exhibit 116: Novogene Corp. - Key offerings
o 10.11 QIAGEN NV
o Exhibit 117: QIAGEN NV - Overview
o Exhibit 118: QIAGEN NV - Product / Service
o Exhibit 119: QIAGEN NV - Key news
o Exhibit 120: QIAGEN NV - Key offerings
o 10.12 Thermo Fisher Scientific Inc.
o Exhibit 121: Thermo Fisher Scientific Inc. - Overview
o Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 123: Thermo Fisher Scientific Inc. - Key news
o Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
Exhibits90: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
Exhibits91: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
Exhibits92: Exact Sciences Corp. - Overview
Exhibits93: Exact Sciences Corp. - Product / Service
Exhibits94: Exact Sciences Corp. - Key offerings
Exhibits95: F. Hoffmann La Roche Ltd. - Overview
Exhibits96: F. Hoffmann La Roche Ltd. - Business segments
Exhibits97: F. Hoffmann La Roche Ltd. - Key news
Exhibits98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits99: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits100: Illumina Inc. - Overview
Exhibits101: Illumina Inc. - Business segments
Exhibits102: Illumina Inc. - Key news
Exhibits103: Illumina Inc. - Key offerings
Exhibits104: Illumina Inc. - Segment focus
Exhibits105: Isogen Life Science BV - Overview
Exhibits106: Isogen Life Science BV - Product / Service
Exhibits107: Isogen Life Science BV - Key offerings
Exhibits108: Myriad Genetics Inc. - Overview
Exhibits109: Myriad Genetics Inc. - Product / Service
Exhibits110: Myriad Genetics Inc. - Key offerings
Exhibits111: Natera Inc. - Overview
Exhibits112: Natera Inc. - Product / Service
Exhibits113: Natera Inc. - Key offerings
Exhibits114: Novogene Corp. - Overview
Exhibits115: Novogene Corp. - Product / Service
Exhibits116: Novogene Corp. - Key offerings
Exhibits117: QIAGEN NV - Overview
Exhibits118: QIAGEN NV - Product / Service
Exhibits119: QIAGEN NV - Key news
Exhibits120: QIAGEN NV - Key offerings
Exhibits121: Thermo Fisher Scientific Inc. - Overview
Exhibits122: Thermo Fisher Scientific Inc. - Business segments
Exhibits123: Thermo Fisher Scientific Inc. - Key news
Exhibits124: Thermo Fisher Scientific Inc. - Key offerings
Exhibits125: Thermo Fisher Scientific Inc. - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Breast Cancer Liquid Biopsy Testing Devices Market 2022-2026
Technavio has been monitoring the breast cancer liquid biopsy testing devices market and it is poised to grow by $ 730.4 mn during 2022-2026, accelerating at a CAGR of 23.58% during the forecast period. Our report on the breast cancer liquid biopsy testing devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of breast cancer, increasing preference for non-invasive procedures, and rising number of new product launches and FDA approvals.
The breast cancer liquid biopsy testing devices market analysis includes the type segment and geographic landscape.
Technavio's breast cancer liquid biopsy testing devices market is segmented as below:
By Type
• CTCs and circulating nucleic acids
• Extracellular vesicles
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the technological advances as one of the prime reasons driving the breast cancer liquid biopsy testing devices market growth during the next few years. Also, growing emphasis on breast cancer diagnosis and increasing focus on direct-to-customer marketing will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on breast cancer liquid biopsy testing devices market covers the following areas:
• Breast cancer liquid biopsy testing devices market sizing
• Breast cancer liquid biopsy testing devices market forecast
• Breast cancer liquid biopsy testing devices market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast cancer liquid biopsy testing devices market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Agena Bioscience Inc., Bio Rad Laboratories Inc., Exact Sciences Corp., F. Hoffmann La Roche Ltd., Fluxion Biosciences Inc., Guardant Health Inc., Illumina Inc., Isogen Life Science BV, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., Novogene Corp., OncoDNA SA, Pfizer Inc., QIAGEN NV, SAGA Diagnostics AB, Sysmex Corp., and Thermo Fisher Scientific Inc. Also, the breast cancer liquid biopsy testing devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/global-breast-cancer-liquid-biopsy-testing-devices-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 CTCs and circulating nucleic acids - Market size and forecast 2021-2026
o Exhibit 28: Chart on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
o 5.4 Extracellular vesicles - Market size and forecast 2021-2026
o Exhibit 32: Chart on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 Canada - Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 A. Menarini Industrie Farmaceutiche Riunite Srl
o Exhibit 89: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
o Exhibit 90: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
o Exhibit 91: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
o 10.4 Exact Sciences Corp.
o Exhibit 92: Exact Sciences Corp. - Overview
o Exhibit 93: Exact Sciences Corp. - Product / Service
o Exhibit 94: Exact Sciences Corp. - Key offerings
o 10.5 F. Hoffmann La Roche Ltd.
o Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
o 10.6 Illumina Inc.
o Exhibit 100: Illumina Inc. - Overview
o Exhibit 101: Illumina Inc. - Business segments
o Exhibit 102: Illumina Inc. - Key news
o Exhibit 103: Illumina Inc. - Key offerings
o Exhibit 104: Illumina Inc. - Segment focus
o 10.7 Isogen Life Science BV
o Exhibit 105: Isogen Life Science BV - Overview
o Exhibit 106: Isogen Life Science BV - Product / Service
o Exhibit 107: Isogen Life Science BV - Key offerings
o 10.8 Myriad Genetics Inc.
o Exhibit 108: Myriad Genetics Inc. - Overview
o Exhibit 109: Myriad Genetics Inc. - Product / Service
o Exhibit 110: Myriad Genetics Inc. - Key offerings
o 10.9 Natera Inc.
o Exhibit 111: Natera Inc. - Overview
o Exhibit 112: Natera Inc. - Product / Service
o Exhibit 113: Natera Inc. - Key offerings
o 10.10 Novogene Corp.
o Exhibit 114: Novogene Corp. - Overview
o Exhibit 115: Novogene Corp. - Product / Service
o Exhibit 116: Novogene Corp. - Key offerings
o 10.11 QIAGEN NV
o Exhibit 117: QIAGEN NV - Overview
o Exhibit 118: QIAGEN NV - Product / Service
o Exhibit 119: QIAGEN NV - Key news
o Exhibit 120: QIAGEN NV - Key offerings
o 10.12 Thermo Fisher Scientific Inc.
o Exhibit 121: Thermo Fisher Scientific Inc. - Overview
o Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 123: Thermo Fisher Scientific Inc. - Key news
o Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
Exhibits90: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
Exhibits91: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
Exhibits92: Exact Sciences Corp. - Overview
Exhibits93: Exact Sciences Corp. - Product / Service
Exhibits94: Exact Sciences Corp. - Key offerings
Exhibits95: F. Hoffmann La Roche Ltd. - Overview
Exhibits96: F. Hoffmann La Roche Ltd. - Business segments
Exhibits97: F. Hoffmann La Roche Ltd. - Key news
Exhibits98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits99: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits100: Illumina Inc. - Overview
Exhibits101: Illumina Inc. - Business segments
Exhibits102: Illumina Inc. - Key news
Exhibits103: Illumina Inc. - Key offerings
Exhibits104: Illumina Inc. - Segment focus
Exhibits105: Isogen Life Science BV - Overview
Exhibits106: Isogen Life Science BV - Product / Service
Exhibits107: Isogen Life Science BV - Key offerings
Exhibits108: Myriad Genetics Inc. - Overview
Exhibits109: Myriad Genetics Inc. - Product / Service
Exhibits110: Myriad Genetics Inc. - Key offerings
Exhibits111: Natera Inc. - Overview
Exhibits112: Natera Inc. - Product / Service
Exhibits113: Natera Inc. - Key offerings
Exhibits114: Novogene Corp. - Overview
Exhibits115: Novogene Corp. - Product / Service
Exhibits116: Novogene Corp. - Key offerings
Exhibits117: QIAGEN NV - Overview
Exhibits118: QIAGEN NV - Product / Service
Exhibits119: QIAGEN NV - Key news
Exhibits120: QIAGEN NV - Key offerings
Exhibits121: Thermo Fisher Scientific Inc. - Overview
Exhibits122: Thermo Fisher Scientific Inc. - Business segments
Exhibits123: Thermo Fisher Scientific Inc. - Key news
Exhibits124: Thermo Fisher Scientific Inc. - Key offerings
Exhibits125: Thermo Fisher Scientific Inc. - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(breast cancer)の最新刊レポート


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/18 10:26

155.35 円

164.28 円

199.02 円

ページTOPに戻る